325 related articles for article (PubMed ID: 26234946)
21. Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins.
Li R; Yuan F; Fu W; Zhang L; Zhang N; Wang Y; Ma K; Li X; Wang L; Zhu WG; Zhao Y
J Biol Chem; 2017 Feb; 292(7):2830-2841. PubMed ID: 28073914
[TBL] [Abstract][Full Text] [Related]
22. Small Molecule Inhibitors of DYRK1A Identified by Computational and Experimental Approaches.
Yoon HR; Balupuri A; Choi KE; Kang NS
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957634
[TBL] [Abstract][Full Text] [Related]
23. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
Coutadeur S; Benyamine H; Delalonde L; de Oliveira C; Leblond B; Foucourt A; Besson T; Casagrande AS; Taverne T; Girard A; Pando MP; Désiré L
J Neurochem; 2015 May; 133(3):440-51. PubMed ID: 25556849
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
25. Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase.
Shao J; Grammatikakis N; Scroggins BT; Uma S; Huang W; Chen JJ; Hartson SD; Matts RL
J Biol Chem; 2001 Jan; 276(1):206-14. PubMed ID: 11036079
[TBL] [Abstract][Full Text] [Related]
26. Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.
Erazo T; Moreno A; Ruiz-Babot G; Rodríguez-Asiain A; Morrice NA; Espadamala J; Bayascas JR; Gómez N; Lizcano JM
Mol Cell Biol; 2013 Apr; 33(8):1671-86. PubMed ID: 23428871
[TBL] [Abstract][Full Text] [Related]
27. The Schizosaccharomyces pombe Cdc7 protein kinase required for septum formation is a client protein of Cdc37.
Liang J; Fantes P
Eukaryot Cell; 2007 Jul; 6(7):1089-96. PubMed ID: 17496123
[TBL] [Abstract][Full Text] [Related]
28. Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases.
Terasawa K; Yoshimatsu K; Iemura S; Natsume T; Tanaka K; Minami Y
Mol Cell Biol; 2006 May; 26(9):3378-89. PubMed ID: 16611982
[TBL] [Abstract][Full Text] [Related]
29. Cdc37 is a molecular chaperone with specific functions in signal transduction.
Kimura Y; Rutherford SL; Miyata Y; Yahara I; Freeman BC; Yue L; Morimoto RI; Lindquist S
Genes Dev; 1997 Jul; 11(14):1775-85. PubMed ID: 9242486
[TBL] [Abstract][Full Text] [Related]
30. Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37.
Prince T; Matts RL
J Biol Chem; 2004 Sep; 279(38):39975-81. PubMed ID: 15258137
[TBL] [Abstract][Full Text] [Related]
31. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.
Nguyen TL; Fruit C; Hérault Y; Meijer L; Besson T
Expert Opin Ther Pat; 2017 Nov; 27(11):1183-1199. PubMed ID: 28766366
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and bioevaluation of inhibitors targeting HSP90-CDC37 protein-protein interaction based on a hydrophobic core.
Zhang Q; Wu X; Zhou J; Zhang L; Xu X; Zhang L; You Q; Wang L
Eur J Med Chem; 2021 Jan; 210():112959. PubMed ID: 33109397
[TBL] [Abstract][Full Text] [Related]
33. DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.
Abu Jhaisha S; Widowati EW; Kii I; Sonamoto R; Knapp S; Papadopoulos C; Becker W
Sci Rep; 2017 Jul; 7(1):6420. PubMed ID: 28743892
[TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.
Keramisanou D; Aboalroub A; Zhang Z; Liu W; Marshall D; Diviney A; Larsen RW; Landgraf R; Gelis I
Mol Cell; 2016 Apr; 62(2):260-271. PubMed ID: 27105117
[TBL] [Abstract][Full Text] [Related]
35. Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors.
Czarna A; Wang J; Zelencova D; Liu Y; Deng X; Choi HG; Zhang T; Zhou W; Chang JW; Kildalsen H; Seternes OM; Gray NS; Engh RA; Rothweiler U
J Med Chem; 2018 Sep; 61(17):7560-7572. PubMed ID: 30095246
[TBL] [Abstract][Full Text] [Related]
36. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
[TBL] [Abstract][Full Text] [Related]
37. The molecular chaperone Cdc37 is required for Ste11 function and pheromone-induced cell cycle arrest.
Abbas-Terki T; Donzé O; Picard D
FEBS Lett; 2000 Feb; 467(1):111-6. PubMed ID: 10664467
[TBL] [Abstract][Full Text] [Related]
38. Targeting the HSP90-CDC37-kinase chaperone cycle: A promising therapeutic strategy for cancer.
Wang L; Zhang Q; You Q
Med Res Rev; 2022 Jan; 42(1):156-182. PubMed ID: 33846988
[TBL] [Abstract][Full Text] [Related]
39. Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity.
Kumar K; Man-Un Ung P; Wang P; Wang H; Li H; Andrews MK; Stewart AF; Schlessinger A; DeVita RJ
Eur J Med Chem; 2018 Sep; 157():1005-1016. PubMed ID: 30170319
[TBL] [Abstract][Full Text] [Related]
40. CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.
Miyata Y; Nishida E
Mol Cell Biol; 2004 May; 24(9):4065-74. PubMed ID: 15082798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
